xMAP® Connect Virtual Conference – Inspiring Multiplexing Innovation

Luminex is proud to announce the xMAP® Connect Virtual Conference, hosted online this year by LabRoots. The goal of this conference is to connect fellow xMAP enthusiasts and provide best practices for multiplex assays, virtually from anywhere in the world. Luminex’s xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single […]

Read More…

Rare but Not Alone – Raising Awareness for Rare Diseases

Join us on Rare Disease Day to honor patients, caregivers, doctors, and scientists. On February 29—a day that only occurs once every four years—people around the world will celebrate Rare Disease Day. It’s a special opportunity to think about those who are affected by rare diseases, the researchers and physicians who work to help them, […]

Read More…

CYTO 2019 Highlighted Continued Expansion of Flow Cytometry Applications

From immunophenotyping extracellular vesicles to imaging, diversity of uses was impressive The Luminex team thoroughly enjoyed this year’s CYTO meeting — that’s the annual meeting of the International Society for Advancement of Cytometry — held at the elegant waterfront convention center in Vancouver. As usual, this conference offered a diverse and jam-packed schedule of talks […]

Read More…

At ASM Microbe, Attention on Reimbursement and Drug-Resistant Pathogens

Luminex workshop offered a look at flexible molecular testing for GI cases We’re finally recovering from the whirlwind that is ASM Microbe, the annual mega-conference of the American Society for Microbiology. This year, the event took place in sunny San Francisco, bringing thousands of microbial experts together to discuss the latest advances and challenges in […]

Read More…

Show Your Rare: Help Us Raise Awareness for People Affected by Rare Diseases

February 28 is Rare Disease Day Here at Luminex, we are big fans of Rare Disease Day. Celebrated annually on the last day of February, this day is not just a reminder that we can all be doing more to support patients with rare diseases as well as the caregivers, scientists and clinicians who work […]

Read More…

Five Things We Learned from an xMAP® Power User

DKFZ’s Tim Waterboer has published more xMAP papers than any other user At the fourth annual xMAP® Connect user group meeting held in Amsterdam late last year, we had the good fortune of sitting down with Tim Waterboer, PhD, leader of the Infections and Cancer Epidemiology Group at DKFZ, the German Cancer Research Center. Waterboer […]

Read More…

Are You Ready to Be a Luminex Power User?

Basic and advanced training for Luminex platforms and assay development techniques We’re pleased to announce our next customer training session, which will be held at Luminex corporate headquarters in Austin next year from April 15th to April 18th. Whether you’re a novice or a current user looking to expand your skills, this series of educational […]

Read More…

Webinar: Multiplexed Cytokine Assays Can Explain Complex Disease

Cytokine and anti-cytokine patterns illuminate late-stage patient cases Scientists at Cambridge University Hospital in the UK are using Luminex xMAP® Technology to measure cytokine response, which is helpful for certain diagnoses and prognoses and can also be used to elucidate diseases with complex anti-cytokine patterns. Principal investigator Rainer Döffinger presents several case studies in this […]

Read More…

Webinar: Kidney Function Study Suggests Biomarkers Associated with IgA Nephropathy

xMAP® multiplex assays were used to interrogate samples In work powered in part by Luminex’s xMAP® Technology, scientists have uncovered promising biomarkers that may signal the loss of renal function in people with IgA nephropathy, the most common form of glomerulonephritis. In this 10-minute video presentation, David Wimbury from the University of Leicester shares experimental […]

Read More…

Webinar: Multiplex Assay Offers Improved Freshwater Toxicity Testing

Ecotoxicity program turns to xMAP® Technology for multi-biomarker detection A vital tool for assessing the toxicity of freshwater ecosystems is the tiny Gammarus fossarum, an amphipod crustacean often used as model organisms and bioindicators for ecotoxicology programs. In a 30-minute webinar presentation, Associate Professor Stéphane Azoulay, from the University of Côte d’Azur, described the design […]

Read More…